Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Domagoj Vucic

Showing results (61-70 of 89) with videos related to

Pageof 9
Sort By:
The EMBO Journal|October 4, 2023
cIAPs control RIPK1 kinase activity-dependent and -independent cell death and tissue inflammationFabian Schorn, J Paul Werthenbach, Mattes Hoffmann, et al.
Science Translational Medicine|December 20, 2023
Inhibition of RIP1 improves immune reconstitution and reduces GVHD mortality while preserving graft-versus-leukemia effectsMariano Prado-Acosta, Seihwan Jeong, Alberto Utrero-Rico, et al.
Clinical and Translational Science|August 19, 2023
A phase I, randomized, ascending-dose study to assess safety, pharmacokinetics, and activity of GDC-8264, a RIP1 inhibitor, in healthy volunteersNicholas S Jones, Smita Kshirsagar, Vishnu Mohanan, et al.
Biochemistry|July 9, 2003
Structure and function analysis of peptide antagonists of melanoma inhibitor of apoptosis (ML-IAP)Matthew C Franklin, Saloumeh Kadkhodayan, Heidi Ackerly, et al.
Journal of Medicinal Chemistry|February 21, 2009
Orally bioavailable antagonists of inhibitor of apoptosis proteins based on an azabicyclooctane scaffoldFrederick Cohen, Bruno Alicke, Linda O Elliott, et al.
The Biochemical Journal|October 23, 2008
Ubiquitin binding modulates IAP antagonist-stimulated proteasomal degradation of c-IAP1 and c-IAP2(1)John W Blankenship, Eugene Varfolomeev, Tatiana Goncharov, et al.
Science (New York, N.Y.)|February 22, 2014
Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosisKim Newton, Debra L Dugger, Katherine E Wickliffe, et al.
Molecular & Cellular Proteomics : MCP|November 5, 2010
Improved quantitative mass spectrometry methods for characterizing complex ubiquitin signalsLilian Phu, Anita Izrael-Tomasevic, Marissa L Matsumoto, et al.
Cell Death and Differentiation|August 13, 2016
Coordinated ubiquitination and phosphorylation of RIP1 regulates necroptotic cell deathM Cristina de Almagro, Tatiana Goncharov, Anita Izrael-Tomasevic, et al.
Cell Death & Disease|April 8, 2021
Genetic inactivation of RIP1 kinase activity in rats protects against ischemic brain injuryKimberly Stark, Tatiana Goncharov, Eugene Varfolomeev, et al.
Pageof 9

Showing results (61-70 of 89) with videos related to

Sort By:
Pageof 9
The EMBO Journal|October 4, 2023
cIAPs control RIPK1 kinase activity-dependent and -independent cell death and tissue inflammationFabian Schorn, J Paul Werthenbach, Mattes Hoffmann, et al.
Science Translational Medicine|December 20, 2023
Inhibition of RIP1 improves immune reconstitution and reduces GVHD mortality while preserving graft-versus-leukemia effectsMariano Prado-Acosta, Seihwan Jeong, Alberto Utrero-Rico, et al.
Clinical and Translational Science|August 19, 2023
A phase I, randomized, ascending-dose study to assess safety, pharmacokinetics, and activity of GDC-8264, a RIP1 inhibitor, in healthy volunteersNicholas S Jones, Smita Kshirsagar, Vishnu Mohanan, et al.
Biochemistry|July 9, 2003
Structure and function analysis of peptide antagonists of melanoma inhibitor of apoptosis (ML-IAP)Matthew C Franklin, Saloumeh Kadkhodayan, Heidi Ackerly, et al.
Journal of Medicinal Chemistry|February 21, 2009
Orally bioavailable antagonists of inhibitor of apoptosis proteins based on an azabicyclooctane scaffoldFrederick Cohen, Bruno Alicke, Linda O Elliott, et al.
The Biochemical Journal|October 23, 2008
Ubiquitin binding modulates IAP antagonist-stimulated proteasomal degradation of c-IAP1 and c-IAP2(1)John W Blankenship, Eugene Varfolomeev, Tatiana Goncharov, et al.
Science (New York, N.Y.)|February 22, 2014
Activity of protein kinase RIPK3 determines whether cells die by necroptosis or apoptosisKim Newton, Debra L Dugger, Katherine E Wickliffe, et al.
Molecular & Cellular Proteomics : MCP|November 5, 2010
Improved quantitative mass spectrometry methods for characterizing complex ubiquitin signalsLilian Phu, Anita Izrael-Tomasevic, Marissa L Matsumoto, et al.
Cell Death and Differentiation|August 13, 2016
Coordinated ubiquitination and phosphorylation of RIP1 regulates necroptotic cell deathM Cristina de Almagro, Tatiana Goncharov, Anita Izrael-Tomasevic, et al.
Cell Death & Disease|April 8, 2021
Genetic inactivation of RIP1 kinase activity in rats protects against ischemic brain injuryKimberly Stark, Tatiana Goncharov, Eugene Varfolomeev, et al.
Pageof 9